Download PDF
Rofo 2018; 190(09): 836-846
DOI: 10.1055/a-0598-5134
Review
© Georg Thieme Verlag KG Stuttgart · New York

Current Technique and Application of Percutaneous Cryotherapy

Article in several languages: English | deutsch
Andreas H. Mahnken
  Department of Diagnostic&Interventional Radiology, Philipps-University Marburg, Germany
,
Alexander Marc König
  Department of Diagnostic&Interventional Radiology, Philipps-University Marburg, Germany
,
Jens Holger Figiel
  Department of Diagnostic&Interventional Radiology, Philipps-University Marburg, Germany
› Author Affiliations
Further Information

Publication History

01 February 2018

27 February 2018

Publication Date:
17 April 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Purpose Local ablative therapies have become an established treatment option in interventional oncology. Radiofrequency ablation (RFA) and microwave ablation (MWA) are a standard of care in the treatment of hepatocellular carcinoma (HCC). Currently, there is an increasing interest in cryotherapy, one of the oldest ablation techniques. It has some unique characteristics with regard to technology and mechanism of action.

Materials and Methods A systematic literature search using the terms cryotherapy, cryosurgery and cryoablation was performed. Selected studies are presented dealing with the mechanism of action, cryobiology and clinical use of percutaneous, image-guided cryoablation. Recent developments and perspectives are presented.

Results Cryotherapy is increasingly used and has been included in guidelines for selected tumor entities such as renal cell carcinoma. Cryo-immunotherapy and combination treatments are future areas of interest.

Conclusion Cryoabalation may be used in many indications. Its major advantages are its unique visualization and the anesthesiologic effects of cold. While there are only a few prospectively randomized trials, the existing data on the use of cryoablation is promising. Its use appears to be justified in selected tumors, oligometastatic patients and for palliative indications.

Key Points 

  • Interventionalists need to know about the unique characteristics and advantages of cryoablation.

  • Proper patient selection and optimal image guidance are essential for successful cryotherapy.

  • Cryoablation offers unique advantages such as anesthesiologic effects and characteristic imaging features.

  • The lack of prospective randomized trials is a key disadvantage of cryoablation.

Citation Format

  • Mahnken AH, König AM, Figiel JH. Current Technique and Application of Percutaneous Cryotherapy. Fortschr Röntgenstr 2018; 190: 836 – 846

Key words

cryoablation - oncology - ablation - neoplasm - cancer - image-guided
 

  • References

  • 1 Gage AA. History of cryosurgery. Semin Surg Oncol 1998; 14: 99-109
    CrossrefPubMedGoogle Scholar
  • 2 Arnott J. Practical illustrations of the remedial efficacy of a very low or anaesthetic temperature. I. In cancer. Lancet 1850; 2: 257-259
    PubMedGoogle Scholar
  • 3 Pusey WA. The use of carbon dioxide snow in the treatment of nevi and other lesions of the skin. J Am Med Assoc 1907; 49: 1354-1356
    PubMedGoogle Scholar
  • 4 Cooper IS, Lee A. Cryostatic congelation: a system for producing a limited controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 1961; 133: 259-263
    CrossrefPubMedGoogle Scholar
  • 5 Torre D. Alternate cryogens for cryosurgery. J Dermatol Surg 1975; 1: 56-58
    PubMedGoogle Scholar
  • 6 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37: 171-186
    CrossrefPubMedGoogle Scholar
  • 7 Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60 (Suppl. 01) 40-49
    CrossrefPubMedGoogle Scholar
  • 8 Wen J, Duan Y, Zou Y. et al. Cryoablation induces necrosis and apoptosis in lung adenocarcinoma in mice. Technol Cancer Res Treat 2007; 6: 635-640
    CrossrefPubMedGoogle Scholar
  • 9 Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology 2009; 59: 229-243
    CrossrefPubMedGoogle Scholar
  • 10 Shepherd JP, Dawber RP. Wound healing and scarring after cryosurgery. Cryobiology 1984; 21: 157-169
    CrossrefPubMedGoogle Scholar
  • 11 Gage AA, Guest K, Montes M. et al. Effect of varying freezing and thawing rates in experimental cryosurgery. Cryobiology 1985; 22: 175-182
    CrossrefPubMedGoogle Scholar
  • 12 Wansapura JP, Daniel BL, Vigen KK. et al. In vivo MR thermometry of frozen tissue using R2* and signal intensity.. Acad Radiol 2005; 12: 1080-1084
    CrossrefPubMedGoogle Scholar
  • 13 Janzen NK, Perry KT, Han KR. et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol 2005; 173: 1368-1374
    CrossrefPubMedGoogle Scholar
  • 14 Whittaker DK. Degeneration and regeneration of nerves following cryosurgery. Br J Exp Pathol 1974; 55: 595-600
    PubMedGoogle Scholar
  • 15 Beazley RM, Bagley DH, Ketcham AS. The effect of cryosurgery on peripheral nerves. J Surg Res 1974; 16: 231-234
    CrossrefPubMedGoogle Scholar
  • 16 Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23: 109-114
    CrossrefPubMedGoogle Scholar
  • 17 Breen DJ, Bryant TJ, Abbas A. et al. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. BJU Int 2013; 112: 758-765
    CrossrefPubMedGoogle Scholar
  • 18 Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 2014; 37: 1494-1499
    CrossrefPubMedGoogle Scholar
  • 19 Jiang K, Tang K, Guo X. et al. Laparoscopic cryoablation vs. percutaneous cryoablation for treatment of small renal masses: a systematic review and meta-analysis. Oncotarget 2017; 8: 27635-27644
    CrossrefPubMedGoogle Scholar
  • 20 Ko YH, Park HS, Moon duG. et al. A matched-cohort comparison of laparoscopic renal cryoablation using ultra-thin cryoprobes with open partial nephrectomy for the treatment of small renal cell carcinoma. Cancer Res Treat 2008; 40: 184-189
    CrossrefPubMedGoogle Scholar
  • 21 Goyal J, Verma P, Sidana A. et al. Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol 2012; 26: 1413-1419
    CrossrefPubMedGoogle Scholar
  • 22 Thompson RH, Atwell T, Schmit G. et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015; 67: 252-259
    CrossrefPubMedGoogle Scholar
  • 23 Atwell TD, Vlaminck JJ, Boorjian SA. et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control. J Vasc Interv Radiol 2015; 26: 792-799
    CrossrefPubMedGoogle Scholar
  • 24 Moynagh MR, Schmit GD, Thompson RH. et al. Percutaneous cryoablation of clinical T2 ([7 cm) renal masses: technical considerations, complications, and short-term outcomes. J Vasc Interv Radiol 2015; 26: 800-806
    CrossrefPubMedGoogle Scholar
  • 25 Wang C, Wang H, Yang W. et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 2015; 61: 1579-1590
    CrossrefPubMedGoogle Scholar
  • 26 Ei S, Hibi T, Tanabe M. et al. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. Ann Surg Oncol 2015; 22: 1294-1300
    CrossrefPubMedGoogle Scholar
  • 27 Wu S, Hou J, Ding Y. et al. Cryoablation versus radiofrequency ablation for hepatic malignancies: a systematic review and literature-based analysis. Med (Baltimore) 2015; 94: e2252
    CrossrefPubMedGoogle Scholar
  • 28 Zhou L, Yang YP, Feng YY. Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: a pilot clinical study. Ai Zheng 2009; 28: 45-48
    PubMedGoogle Scholar
  • 29 Chen HW, Lai EC, Zhen ZJ. et al. Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. Int J Surg 2011; 9: 188-191
    CrossrefPubMedGoogle Scholar
  • 30 Littrup PJ, Aoun HD, Adam B. et al. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U. S. series. Abdom Radiol (NY) 2016; 41: 767-780
    CrossrefPubMedGoogle Scholar
  • 31 Glazer DI, Tatli S, Shyn PB. et al. Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes. Am J Roentgenol 2017; 209: 1381-1389
    CrossrefPubMedGoogle Scholar
  • 32 Bang HJ, Littrup PJ, Currier BP. et al. Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations. ISRN Minim Invasive Surg 2012; 2012
    PubMedGoogle Scholar
  • 33 Zhang W, Yu H, Guo Z. et al. Percutaneous cryoablation of liver metastases from breast cancer: initial experience in 17 patients. Clin Radiol 2014; 69: 231-238
    CrossrefPubMedGoogle Scholar
  • 34 Gao W, Guo Z, Zhang X. et al. Percutaneous cryoablation of ovarian cancer metastasis to the liver: initial experience in 13 patients. Int J Gynecol Cancer 2015; 25: 802-808
    CrossrefPubMedGoogle Scholar
  • 35 Bilchik AJ, Sarantou T, Foshag LJ. et al. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery 1997; 122: 1040-1048
    CrossrefPubMedGoogle Scholar
  • 36 Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211: 68-72
    CrossrefPubMedGoogle Scholar
  • 37 Moore W, Talati R, Bhattacharji P. et al. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol 2015; 26: 312-319
    CrossrefPubMedGoogle Scholar
  • 38 Niu L, Chen J, Yao F. et al. Percutaneous cryoablation for stage IV lung cancer: a retrospective analysis. Cryobiology 2013; 67: 151-155
    CrossrefPubMedGoogle Scholar
  • 39 de Baere T, Tselikas L, Woodrum D. et al. Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year. J Thorac Oncol 2015; 10: 1468-1474
    CrossrefPubMedGoogle Scholar
  • 40 Liu S, Ren R, Liu M. et al. MR imaging-guided percutaneous cryotherapy for lung tumors: initial experience. J Vasc Interv Radiol 2014; 25: 1456-1462
    CrossrefPubMedGoogle Scholar
  • 41 Chou HP, Chen CK, Shen SH. et al. Percutaneous cryoablation for inoperable malignant lung tumors: midterm results. Cryobiology 2015; 70: 60-65
    CrossrefPubMedGoogle Scholar
  • 42 Yamauchi Y, Izumi Y, Kawamura M. et al. Percutaneous cryoablation of pulmonary metastases from colorectal cancer. PLoS One 2011; 6: e27086
    CrossrefPubMedGoogle Scholar
  • 43 McDevitt JL, Mouli SK, Nemcek AA. et al. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications. J Vasc Interv Radiol 2016; 27: 1371-1379
    CrossrefPubMedGoogle Scholar
  • 44 Edwards MJ, Broadwater R, Tafra L. et al. Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice. Am J Surg 2004; 188: 221-224
    CrossrefPubMedGoogle Scholar
  • 45 Kaufman CS, Littrup PJ, Freman-Gibb LA. et al. Office-based cryoablation of breast fibroadenomas: 12-month followup. J Am Coll Surg 2004; 198: 914-923
    CrossrefPubMedGoogle Scholar
  • 46 Sabel MS, Kaufman CS, Whitworth P. et al. Cryoablation of early-stage breast cancer: work-in-progress report of a multiinstitutional trial. Ann Surg Oncol 2004; 11: 542-549
    PubMedGoogle Scholar
  • 47 Pfleiderer SO, Freesmeyer MG, Marx C. et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol 2002; 12: 3009-3014
    PubMedGoogle Scholar
  • 48 Mauri G, Sconfienza LM, Pescatori LC. et al. Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis. Eur Radiol 2017; 27: 3199-3210
    CrossrefPubMedGoogle Scholar
  • 49 Simmons RM, Ballman KV, Cox C. et al. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (Alliance) Z1072. Ann Surg Oncol 2016; 23: 2438-2445
    CrossrefPubMedGoogle Scholar
  • 50 Cazzato RL, de Lara CT, Buy X. et al. Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive nonsurgical patients. Cardiovasc Interv Radiol 2015; 38: 1237-1243
    CrossrefPubMedGoogle Scholar
  • 51 Greenway RM, Schlossberg L, Dooley WC. Fifteen-year series of skin-sparing mastectomy for stage 0 to 2 breast cancer. Am J Surg 2005; 190: 918-922
    PubMedGoogle Scholar
  • 52 Tomasian A, Wallace A, Northrup B. et al. Spine cryoablation: pain palliation and local tumor control for vertebral metastases. Am J Neuroradiol 2016; 37: 189-195
    CrossrefPubMedGoogle Scholar
  • 53 Callstrom MR, Dupuy DE, Solomon SB. et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119: 1033-1041
    CrossrefPubMedGoogle Scholar
  • 54 Prologo JD, Passalacqua M, Patel I. et al. Image-guided cryoablation for the treatment of painful musculoskeletal metastatic disease: a single-center experience. Skeletal Radiol 2014; 43: 1551-1559
    CrossrefPubMedGoogle Scholar
  • 55 Li F, Wang W, Li L. et al. An effective therapy to painful bone metastases: cryoablation combined with zoledronic acid. Pathol Oncol Res 2014; 20: 885-891
    CrossrefPubMedGoogle Scholar
  • 56 Tsoumakidou G, Too CW, Garnon J. et al. Treatment of a spinal aneurysmal bone cyst using combined image-guided cryoablation and cementoplasty. Skeletal Radiol 2015; 44: 285-289
    CrossrefPubMedGoogle Scholar
  • 57 Griauzde J, Gemmete JJ, Farley F. Successful treatment of a Musculoskeletal Tumor Society grade 3 aneurysmal bone cyst with N-butyl cyanoacrylate embolization and percutaneous cryoablation. J Vasc Interv Radiol 2015; 26: 905-909
    CrossrefPubMedGoogle Scholar
  • 58 Havez M, Lippa N, Al-Ammari S. et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol 2014; 37: 1500-1506
    CrossrefPubMedGoogle Scholar
  • 59 Schmitz JJ, Schmit GD, Atwell TD. et al. Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience. Am J Roentgenol 2016; 207: 190-195
    CrossrefPubMedGoogle Scholar
  • 60 Fan W, Niu L, Wang Y. et al. Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy. Oncotarget 2016; 7: 42639-42649
    PubMedGoogle Scholar
  • 61 Fan WZ, Niu LZ, Wang Y. et al. Initial Experience: Alleviation of Pain with Percutaneous CT-Guided Cryoablation for Recurrent Retroperitoneal Soft-Tissue Sarcoma. J Vasc Interv Radiol 2016; 27: 1798-1805
    CrossrefPubMedGoogle Scholar
  • 62 McMenomy BP, Kurup AN, Johnson GB. et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 2013; 24: 207-213
    CrossrefPubMedGoogle Scholar
  • 63 Littrup PJ, Bang HJ, Currier BP. et al. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol 2013; 24 (12) 1817-1825
    CrossrefPubMedGoogle Scholar
  • 64 Deschamps F, Farouil G, Ternes N. et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients?. Eur Radiol 2014; 24: 1971-1980
    CrossrefPubMedGoogle Scholar
  • 65 Silva RD, Kim FJ. Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? – The Cancer. Int Braz J Urol 2015; 41: 5-9
    CrossrefPubMedGoogle Scholar
  • 66 Reis LO, Carter HB. The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?. Int Braz J Urol 2015; 41: 10-14
    CrossrefPubMedGoogle Scholar
  • 67 Stephenson AJ, Scardino PT, Bianco Jr FJ. et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004; 172: 2239-2243
    CrossrefPubMedGoogle Scholar
  • 68 Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 2012; 109: 1648-1654
    PubMedGoogle Scholar
  • 69 Valerio M, Cerantola Y, Eggener SE. et al. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Eur Urol 2017; 71: 17-34
    CrossrefPubMedGoogle Scholar
  • 70 Pisters LL, Rewcastle JC, Donnelly BJ. et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008; 180: 559-564
    CrossrefPubMedGoogle Scholar
  • 71 Gangi A, Tsoumakidou G, Abdelli O. et al. Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol 2012; 22: 1829-1835
    CrossrefPubMedGoogle Scholar
  • 72 Overduin CG, Jenniskens SFM, Sedelaar JPM. et al. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes. Eur Radiol 2017; 27: 4828-4836
    CrossrefPubMedGoogle Scholar
  • 73 Figiel J, Koenig A, Hegele A. et al. MRI-guided percutaneous transgluteal ablation of unilateral prostate carcinoma: initial experiences and results. Insights into Imaging 2018; 9 (Suppl. 01) S 228
    PubMedGoogle Scholar
  • 74 Welch BT, Atwell TD, Nichols DA. et al. Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. Radiology 2011; 258: 301-307
    CrossrefPubMedGoogle Scholar
  • 75 Guenette JP, Tuncali K, Himes N. et al. Percutaneous Image-Guided Cryoablation of Head and Neck Tumors for Local Control, Preservation of Functional Status, and Pain Relief. Am J Roentgenol 2017; 208: 453-458
    CrossrefPubMedGoogle Scholar
  • 76 Patiutko IuI, Barkanov AI, Kholikov TK. et al. The combined treatment of locally disseminated pancreatic cancer using cryosurgery. Vopr Onkol 1991; 37: 695-700 [Russisch]
    PubMedGoogle Scholar
  • 77 Niu L, He L, Zhou L at al. Percutaneous ultrasonography and computed tomography guided pancreatic cryoablation: feasibility and safety assessment. Cryobiology 2012; 65: 301-307
    CrossrefPubMedGoogle Scholar
  • 78 Luo XM, Niu LZ, Chen JB. et al. Advances in cryoablation for pancreatic cancer. World J Gastroenterol 2016; 22: 790-800
    CrossrefPubMedGoogle Scholar
  • 79 Coupal TM, Mallinson PI, Munk PL. et al. CT-guided percutaneous cryoablation for osteoid osteoma: initial experience in adults. Am J Roentgenol 2014; 202: 1136-1139
    CrossrefPubMedGoogle Scholar
  • 80 Whitmore MJ, Hawkins CM, Prologo JD. et al. Cryoablation of Osteoid Osteoma in the Pediatric and Adolescent Population. J Vasc Interv Radiol 2016; 27: 232-237
    CrossrefPubMedGoogle Scholar
  • 81 Cazzato RL, Garnon J, Ramamurthy N. et al. Percutaneous MR-Guided Cryoablation of Morton's Neuroma: Rationale and Technical Details After the First 20 Patients. Cardiovasc Intervent Radiol 2016; 39: 1491-1498
    CrossrefPubMedGoogle Scholar
  • 82 Prologo JD, Gilliland CA, Miller M. et al. Percutaneous Image-Guided Cryoablation for the Treatment of Phantom Limb Pain in Amputees: A Pilot Study. J Vasc Interv Radiol 2017; 28: 24-34.e4
    CrossrefPubMedGoogle Scholar
  • 83 Cornelis F, Havez M, Labrèze C. Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol 2013; 24: 823-827
    CrossrefPubMedGoogle Scholar
  • 84 Woolen S, Gemmete JJ. Treatment of Residual Facial Arteriovenous Malformations after Embolization with Percutaneous Cryotherapy. J Vasc Interv Radiol 2016; 27: 1570-1575
    CrossrefPubMedGoogle Scholar
  • 85 den Brok MH, Sutmuller RP, Nierkens S. et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res 2006; 66: 7285-7292
    CrossrefPubMedGoogle Scholar
  • 86 Mehta A, Oklu R, Sheth RA. Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response?. Gastroenterol Res Pract 2016; 2016: 9251375
    PubMedGoogle Scholar
  • 87 Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014; 14: 199-208
    CrossrefPubMedGoogle Scholar
  • 88 Redondo P, del Olmo J, López-Diaz de Cerio A. et al. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. J Invest Dermatol 2007; 127: 1673-1680
    CrossrefPubMedGoogle Scholar
  • 89 den Brok MH, Sutmuller RP, Nierkens S. et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 2006; 95: 896-905
    CrossrefPubMedGoogle Scholar
  • 90 Levy MY, Sidana A, Chowdhury WH. et al. Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation. J Pharmacol Exp Ther 2009; 330: 596-601
    CrossrefPubMedGoogle Scholar
  • 91 Niu L, Chen J, He L. et al. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas 2013; 42: 1143-1149
    CrossrefPubMedGoogle Scholar
  • 92 Le Pivert PJ, Morrison DR, Haddad RS. et al. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Technol Cancer Res Treat 2009; 8: 207-216
    CrossrefPubMedGoogle Scholar
  • 93 Benson JW. Regional chemotherapy and local cryotherapy for cancer. Oncology 1972; 26: 134-151
    CrossrefPubMedGoogle Scholar
  • 94 Homasson JP, Pecking A, Roden S. et al. Tumor fixation of bleomycin labeled with 57 cobalt before and after cryotherapy of bronchial carcinoma. Cryobiology 1992; 29: 543-548
    CrossrefPubMedGoogle Scholar
  • 95 Mir LM, Rubinsky B. Treatment of cancer with cryochemotherapy. Br J Cancer 2002; 86: 1658-1660
    PubMedGoogle Scholar
  • 96 Li Z, Fu Y, Li Q. et al. Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases. Tumour Biol 2014; 35: 10841-10848
    CrossrefPubMedGoogle Scholar
  • 97 Xu KC, Niu LZ, He WB. et al. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol 2008; 14: 1430-1436
    CrossrefPubMedGoogle Scholar
  • 98 Khanevich MD, Manikhas GM, Vashkurov SM. et al. Combination of vessel embolization and cryotherapy in surgical treatment of soft tissue sarcomas. Vestn Khir Im I I Grek 2015; 174: 39-44 [Russisch]
    PubMedGoogle Scholar
  • 99 Burton SA, Paljug WR, Kalnicki S. et al. Hypothermia-enhanced human tumor cell radiosensitivity. Cryobiology 1997; 35: 70-78
    CrossrefPubMedGoogle Scholar
  • 100 Niu L, Zhou L, Xu K. et al. Combination of cryosurgery and Iodine-125 seeds brachytherapy for lung cancer. J Thorac Dis 2012; 4: 504-507
    PubMedGoogle Scholar
  • 101 Xu K, Niu L, Mu F. et al. Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer. Gland Surg 2013; 2: 91-99
    PubMedGoogle Scholar